RAPS: Commenters ask FDA to allow rare disease classification for disseminated coccidioidomycosis drugs Stakeholders are asking the US Food and Drug Administration (FDA) to treat disseminated coccidioidomycosis as a rare disease for trial design and regulatory purposes. In September, FDA published a ... Commenters ask FDA to allow rare disease classification for disseminated coccidioidomycosis drugs The New England Journal of Medicine: Disseminated Coccidioidomycosis Treated with Interferon-γ and Dupilumab We describe a case of life-threatening disseminated coccidioidomycosis in a previously healthy child.

Context Explanation

Like most patients with disseminated coccidioidomycosis, this child had no genomic evidence of any ... The US Food and Drug Administration (FDA) has published a draft guidance on developing drugs intended to treat disseminated coccidioidomycosis from Coccidioides immitis and C. posadasii. It focuses on ...

Insight Material

Coccidioidomycosis, or Valley fever, is increasingly prevalent in California, but cases in children are not as well described as those in adults. Two recent studies describe the clinical features of ... California is reporting 6,761 cases of valley fever, also known as coccidioidomycosis, through July this year. Here's what you need to know about the potentially deadly fungal infection. California ...

Final Conclusion